Before trying peptides, he says he had been to his GP and was given physiotherapy sessions, but despite consistently doing the exercises he was told to do, it wasn't getting any better
Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 39325560] PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context
A 2024 narrative review synthesizing data across musculoskeletal applications further highlighted BPC-157s potential to promote controlled blood vessel growth and protect neuromuscular connections
Clinical Trial Outcomes with Monotherapy The REDEFINE 1 trial demonstrated that cagrilintide monotherapy at the 4.5 mg maintenance dose produced mean body weight reductions of approximately 10.8% from baseline after 32 weeks of treatment [4]
Depressed levels of methylcobalamin, vitamin B12, and abnormal Schillings test have been reported in patients receiving octreotide
If you think you might be suffering from B12 deficiency, consult with your doctor to discuss what avenues of treatment are available for you to pursue